These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 7711824

  • 1. Interferon beta for treatment of multiple sclerosis.
    Wilson BA.
    Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of multiple sclerosis with beta-interferon.
    Poser CM.
    Neuroepidemiology; 2008 Apr; 31(3):157-8. PubMed ID: 18716413
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ, Polman CH.
    Ned Tijdschr Geneeskd; 1996 Nov 02; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract] [Full Text] [Related]

  • 4. Issues in pharmaceutical lotteries: the case of interferon beta-1b.
    Manocchia M, Lasagna L.
    Clin Pharmacol Ther; 1997 Sep 02; 62(3):241-7. PubMed ID: 9333099
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P.
    Rev Med Brux; 1999 Sep 02; 20(4):A264-7. PubMed ID: 10523902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [High doses of interferon in the treatment of multiple sclerosis].
    Muñoz D.
    Rev Neurol; 1999 Sep 02; 32(9):899. PubMed ID: 11424041
    [No Abstract] [Full Text] [Related]

  • 9. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, Pedespan JM, Van Hulle C, Vermersch P, Ponsot G.
    J Pediatr; 2001 Sep 02; 139(3):443-6. PubMed ID: 11562627
    [Abstract] [Full Text] [Related]

  • 10. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug 02; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract] [Full Text] [Related]

  • 11. The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
    Pender MP.
    J Clin Neurosci; 2001 Jul 02; 8(4):381-2. PubMed ID: 11437589
    [No Abstract] [Full Text] [Related]

  • 12. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
    Hodgkinson SJ.
    J Clin Neurosci; 2001 Jul 02; 8(4):378-9. PubMed ID: 11437587
    [No Abstract] [Full Text] [Related]

  • 13. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against.
    Macdonell R.
    J Clin Neurosci; 2001 Jul 02; 8(4):379-81. PubMed ID: 11437588
    [No Abstract] [Full Text] [Related]

  • 14. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
    Oger J, Gibbs E.
    Nat Clin Pract Neurol; 2006 Feb 02; 2(2):76-7. PubMed ID: 16932528
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [New trends, clinical questions and long-term experiences. Therapy of multiple sclerosis with interferon beta-1b].
    Nervenarzt; 1998 Nov 02; 69(11 Suppl Therapie D):1-8. PubMed ID: 9845885
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of multiple sclerosis with interferon beta 1b.
    Dhib-Jalbut S, McFarland HF.
    Baillieres Clin Neurol; 1997 Oct 02; 6(3):467-80. PubMed ID: 10101584
    [Abstract] [Full Text] [Related]

  • 20. [Interferon beta-1a].
    Taéron C.
    Rev Infirm; 2004 May 02; (101):39-40. PubMed ID: 15984751
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.